The Krill Ageing Muscle Mechanisms (KAMM) Study

NCT ID: NCT06296875

Last Updated: 2025-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to determine the mechanisms via which krill oil supplementation increases muscle strength and whether this translates to improvements in gait and functional characteristics in older adults. The studies we will carry out will establish, in healthy older adults, the effects of 6 months of supplementation with krill oil

Objective 1) Muscle structure and function Hypothesis: Krill oil supplementation will increase muscle size and strength alongside positive changes in muscle architecture (pennation angle and fascicle length).

Objective 2) Neuromuscular control and central nervous system (CNS) function Hypothesis: Krill oil supplementation will improve Neuromuscular Junction (NMJ) transmission stability and increase central drive and intramuscular coherence, as a measure of muscle synergy.

Objective 3) Gait and functional characteristics Hypothesis: Krill oil supplementation will improve gait and functional characteristics.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

1:1 parallel group design
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
All supplements will be matched for taste and look

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vegetable oil

4g/day vegetable oil for 24 weeks

Group Type PLACEBO_COMPARATOR

Vegetable oil

Intervention Type DIETARY_SUPPLEMENT

mixed vegetable oil

Krill oil

4/g/day krill oil for 24 weeks

Group Type ACTIVE_COMPARATOR

Krill oil

Intervention Type DIETARY_SUPPLEMENT

Krill oil

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vegetable oil

mixed vegetable oil

Intervention Type DIETARY_SUPPLEMENT

Krill oil

Krill oil

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

(SuperbaBoost)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* body mass index (BMI) \</= 30 kg/m2
* Age \>/= 65 years
* Capacity to consent
* Living within the Glasgow area

Exclusion Criteria

* Diabetes mellitus
* Severe cardiovascular disease
* Seizure disorders
* Uncontrolled hypertension (\>150/90mmHg)
* Active cancer or cancer that has been in remission \<5 years
* Participation in any resistance exercise training within the last 6 months
* Impairments which may limit ability to perform assessments of muscle function
* Dementia
* Fish/shellfish allergy
* Taking medication known to affect muscle (e.g. steroids, Selective serotonin reuptake inhibitors) or anticoagulants (e.g. warfarin)
* Taking omega-3 supplements in the last 3 months
* Regularly consuming 1 or more portions of oily fish per week
* Not able to understand English
Minimum Eligible Age

65 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Glasgow

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stuart Gray

Professor of Muscle and Metabolic Health

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Glasgow

Glasgow, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stuart Gray

Role: CONTACT

+441413302569

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stuart R Gray, PhD

Role: primary

01413302569

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KAMM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.